Updated: September 16, 2024

CCP: Iron Deficiency

Iron Deficiency

Objective: Monitor for and manage iron deficiency
Patient population: Adult patients (>18 years) with known diagnosis of IBD

Highlight Box

Parenteral iron is recommended over oral iron; however, both oral and parenteral iron are effective in correcting iron deficiency anemia. The decision of the optimal form of iron for each individual patient, remains at the discretion of the prescriber, based on the patients’ characteristics and needs.

 

Introduction

This care protocol provides a general guideline for monitoring and managing iron deficiency in adults with inflammatory bowel disease. The availability of the listed options for iron replacement may vary across organizations.

IBD Provider

1. Review CBC (hemoglobin, MCV), Fe, Ferritin, Transferrin, TIBC.

2. Confirm iron deficiency (Ferritin <20 g/L or iron saturations <15%) or if active disease, Ferritin < 100 g/L, Iron saturations <15%.

3. Review hemoglobin

a. If Hb <70 g/L –> consider urgent PRBC transfusion if symptomatic or urgent iron infusion (if asymptomatic) and repeat Hb in 2 weeks

b. If Hb = 70-100g/L –> iron infusion and repeat Hb in 2 months

c. If Hb >100g/L –> oral iron supplements, if intolerant, organize iron infusion, repeat Hb, Ferritin, Fe, Iron studies, CRP in 3 months

4. See Table 1 for Iron replacement options.

5. Arrange for IV iron replacement per protocol.

6. Inform the family physician of the plan for iron replacement.

Table 1: Options for iron replacement

Iron Formulation* Route Common Dose Elemental Iron Equivalence
Ferrous Gluconate Oral 300mg/tablet 35mg
Ferrous Sulfate Oral 300mg/tablet 60mg
Ferrous Fumerate Oral 300mg/tablet 100mg
Iron Polysaccharide (Feramax) Oral 150mg/tablet 150mg
Heme Iron Polypeptide (Proferrin) Oral 398mg/tablet 11mg
Iron Sucrose (Venofer) Intravenous Variable based on patient requirement (100-300mg/dose) 20mg/mL
Sodium Ferric Gluconate (Ferrlecit) Intravenous 125mg 125mg
Iron Isomaltoside (Monoferric) Intravenous Variable based on patient requirement (see table below) 100mg/mL

*This is not a comprehensive list of all iron products available

Simplified dosing table for Iron isomaltoside (Maximum single dose is 1.5g or 20mg/kg, whichever is less)

Hemoglobin (g/L) Weight <50 kg Weight 50-69kg Weight ≥70kg
≥ 100 g/L 500mg 1g 1.5mg
< 100 g/L 500mg 1.5g 2mg

 

References

Lim, W., Afif, W., Knowles, S., Lim, G., Lin, Y., Mothersill, C., Nistor, I., Rehman, F., Song, C. and Xenodemetropoulos, T. (2019), Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. Vox Sang, 114: 363- 373. https://doi.org/10.1111/vox.12773

Abhyankar, A., & Moss, A. C. (2015). Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflammatory bowel diseases, 21(8), 1976–1981. https://doi.org/10.1097/MIB.0000000000000386

Macdougall, I. C., Comin-Colet, J., Breymann, C., Spahn, D. R., & Koutroubakis, I. E. (2020). Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency. Advances in therapy, 37(5), 1960–2002. https://doi.org/10.1007/s12325-020-01323-z

 

Download PDF version

Go Back to IBD Clinical Care Pathways